1
|
Schmitt A, Reda M, Macaire P, Bellio H, Uwer L, Ilie S, Lorgis V, Hennequin A, Ladoire S, Rederstorff E, Fumoleau P, Isambert N, Bonnin N, You B, Freyer G, Desmoulins I. 147P When a single G-CSF administration is better than longer duration: Example in patients treated by eribulin. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.03.161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
2
|
Trédan O, Wang Q, Pissaloux D, Cassier P, de la Fouchardière A, Fayette J, Desseigne F, Ray-Coquard I, de la Fouchardière C, Frappaz D, Heudel PE, Bonneville-Levard A, Fléchon A, Sarabi M, Guibert P, Bachelot T, Pérol M, You B, Bonnin N, Collard O, Leyronnas C, Attignon V, Baudet C, Sohier E, Villemin JP, Viari A, Boyault S, Lantuejoul S, Paindavoine S, Treillleux I, Rodriguez C, Agrapart V, Corset V, Garin G, Chabaud S, Pérol D, Blay JY. Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial. Ann Oncol 2019; 30:757-765. [PMID: 30865223 DOI: 10.1093/annonc/mdz080] [Citation(s) in RCA: 105] [Impact Index Per Article: 21.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/09/2023] Open
Abstract
BACKGROUND Antitumor activity of molecular-targeted agents is guided by the presence of documented genomic alteration in specific histological subtypes. We aim to explore the feasibility, efficacy and therapeutic impact of molecular profiling in routine setting. PATIENTS AND METHODS This multicentric prospective study enrolled adult or pediatric patients with solid or hematological advanced cancer previously treated in advanced/metastatic setting and noneligible to curative treatment. Each molecular profile was established on tumor, relapse or biopsies, and reviewed by a molecular tumor board (MTB) to identify molecular-based recommended therapies (MBRT). The main outcome was to assess the incidence rate of genomic mutations in routine setting, across specific histological types. Secondary objectives included a description of patients with actionable alterations and for whom MBRT was initiated, and overall response rate. RESULTS Four centers included 2579 patients from February 2013 to February 2017, and the MTB reviewed the molecular profiles achieved for 1980 (76.8%) patients. The most frequently altered genes were CDKN2A (N = 181, 7%), KRAS (N = 177, 7%), PIK3CA (N = 185, 7%), and CCND1 (N = 104, 4%). An MBRT was recommended for 699/2579 patients (27%), and only 163/2579 patients (6%) received at least one MBRT. Out of the 182 lines of MBRT initiated, 23 (13%) partial responses were observed. However, only 0.9% of the whole cohort experienced an objective response. CONCLUSION An MBRT was provided for 27% of patients in our study, but only 6% of patients actually received matched therapy with an overall response rate of 0.9%. Molecular screening should not be used at present to guide decision-making in routine clinical practice outside of clinical trials.This trial is registered with ClinicalTrials.gov, number NCT01774409.
Collapse
Affiliation(s)
- O Trédan
- Departments of Medical Oncology, University Claude Bernard
| | - Q Wang
- Translational Research and Innovation
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - B You
- Department of Medical Oncology, Lyon Sud Hospital Center, CITOHL, Institute of Cancerology, Hospices Civils de Lyon (IC-HCL), Lyon; Faculty of Medicine-Lyon Sud, EMR UCBL/HCL 3738, University of Lyon 1, Oullins
| | - N Bonnin
- Department of Medical Oncology, Lyon Sud Hospital Center, CITOHL, Institute of Cancerology, Hospices Civils de Lyon (IC-HCL), Lyon
| | - O Collard
- Department of Medical Oncology, Lucien Neuwirth Cancer Institute, Saint-Priest-en-Jarez
| | - C Leyronnas
- Department of Medical Oncology, Mutualist Hospital Group, Grenoble
| | | | - C Baudet
- Synergie Lyon Cancer, Bio-Informatics Platform
| | - E Sohier
- Synergie Lyon Cancer, Bio-Informatics Platform
| | | | - A Viari
- Synergie Lyon Cancer, Bio-Informatics Platform
| | - S Boyault
- Translational Research and Innovation
| | | | | | | | - C Rodriguez
- BioPathology, Léon Bérard Cancer center, Lyon
| | - V Agrapart
- Department of Clinical Research and Innovation, Léon Bérard Cancer Center, Lyon, France
| | - V Corset
- Department of Clinical Research and Innovation, Léon Bérard Cancer Center, Lyon, France
| | - G Garin
- Department of Clinical Research and Innovation, Léon Bérard Cancer Center, Lyon, France
| | - S Chabaud
- Department of Clinical Research and Innovation, Léon Bérard Cancer Center, Lyon, France
| | - D Pérol
- Department of Clinical Research and Innovation, Léon Bérard Cancer Center, Lyon, France
| | - J-Y Blay
- Departments of Medical Oncology, University Claude Bernard.
| |
Collapse
|
3
|
Marchais H, Rebika S, Bonnin N, Kémény JL, Paulon C, Chiambaretta F. [Intracardiac tumor causing recurrent central retinal artery occlusions]. J Fr Ophtalmol 2017; 40:e353-e355. [PMID: 29037521 DOI: 10.1016/j.jfo.2016.10.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2016] [Revised: 09/26/2016] [Accepted: 10/10/2016] [Indexed: 11/28/2022]
Affiliation(s)
- H Marchais
- Service d'ophtalmologie, CHU de Clermont-Ferrand, 58, rue de Montalembert, 63000 Clermont-Ferrand, France.
| | - S Rebika
- Service d'ophtalmologie, CHU de Clermont-Ferrand, 58, rue de Montalembert, 63000 Clermont-Ferrand, France
| | - N Bonnin
- Service d'ophtalmologie, CHU de Clermont-Ferrand, 58, rue de Montalembert, 63000 Clermont-Ferrand, France
| | - J L Kémény
- Service d'anatomopathologie, CHU de Clermont-Ferrand, 58, rue de Montalembert, 63000 Clermont-Ferrand, France
| | - C Paulon
- Service d'ophtalmologie, CHU de Clermont-Ferrand, 58, rue de Montalembert, 63000 Clermont-Ferrand, France
| | - F Chiambaretta
- Service d'ophtalmologie, CHU de Clermont-Ferrand, 58, rue de Montalembert, 63000 Clermont-Ferrand, France
| |
Collapse
|
4
|
Le Saux O, Ray-Coquard I, Corset V, Sohier E, Baudet C, Pissaloux D, Wang Q, Chabaud S, Varnier R, Heudel P, Derbel O, You B, Trédan O, Cassier P, Bonnin N, Biron P, Freyer G, Trillet-Lenoir V, Bachelot T, Pérol D, Blay JY. Actionable molecular alterations in advanced gynecologic malignancies: updated results from the ProfiLER program in France. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx511] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
5
|
Varnier R, Ray-Coquard I, Corset V, Baudet C, Pissaloux D, Attignon V, Ezzalfani M, Le Saux O, Heudel P, Derbel O, You B, Tredan O, Cassier P, Bonnin N, Biron P, Freyer G, Trillet-Lenoir V, Bachelot T, Perol D, Blay JY. Actionable molecular alterations in advanced gynecologic malignancies: First results from the ProfiLER program (NCT01774409) in France. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx372.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
6
|
Benoist D’Azy C, Paulon C, Bonnin N, Daniel E, Benoist D’Azy C, Chiambaretta F. Hémorragie maculaire sous-rétinienne révélant une leucémie aiguë myéloide. J Fr Ophtalmol 2017; 40:e55-e57. [DOI: 10.1016/j.jfo.2015.09.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2015] [Revised: 09/21/2015] [Accepted: 09/21/2015] [Indexed: 11/28/2022]
|
7
|
Benoist D'azy C, Bonnin N, Maurin C, Farguette F, Chiambaretta F. [Vitreous hemorrhage as the initial manifestation of familial exudative vitreoretinopathy in an eight-year-old child]. J Fr Ophtalmol 2016; 39:549-53. [PMID: 27230891 DOI: 10.1016/j.jfo.2015.08.016] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2015] [Revised: 08/13/2015] [Accepted: 08/28/2015] [Indexed: 10/21/2022]
Abstract
PURPOSE To report vitreous hemorrhage as the initial manifestation of familial exudative vitreoretinopathy (FEVR). METHODS Case report. RESULTS An 8-year-old child presented with vitreous hemorrhage leading to the discovery of large neovascularization. Fundus examination and fluorescein angiography showed the typical appearance of FEVR. A genetic study confirmed the diagnosis. Treatment by laser photocoagulation was performed with good recovery of visual acuity. CONCLUSION Ophthalmologists should be aware of familial exudative vitreoretinopathy (FEVR) so as not to misdiagnose this sight-threatening disease.
Collapse
Affiliation(s)
- C Benoist D'azy
- RMND-M2O Pole, Ophthalmology department, Clermont-Ferrand University Hospital, 58, rue Montalembert, 63000 Clermont-Ferrand, France
| | - N Bonnin
- RMND-M2O Pole, Ophthalmology department, Clermont-Ferrand University Hospital, 58, rue Montalembert, 63000 Clermont-Ferrand, France; EA 7281 R2D2, Biochemistery Laboratory, Medicine Faculty, Auvergne University, 63000 Clermont-Ferrand, France; Centre d'ophtalmologie du Zénith, bâtiment Trident E, 46, rue de Sarliève , 63800 Cournon D'Auvergne, France.
| | - C Maurin
- RMND-M2O Pole, Ophthalmology department, Clermont-Ferrand University Hospital, 58, rue Montalembert, 63000 Clermont-Ferrand, France
| | - F Farguette
- RMND-M2O Pole, Ophthalmology department, Clermont-Ferrand University Hospital, 58, rue Montalembert, 63000 Clermont-Ferrand, France; Centre d'ophtalmologie du Zénith, bâtiment Trident E, 46, rue de Sarliève , 63800 Cournon D'Auvergne, France
| | - F Chiambaretta
- RMND-M2O Pole, Ophthalmology department, Clermont-Ferrand University Hospital, 58, rue Montalembert, 63000 Clermont-Ferrand, France; EA 7281 R2D2, Biochemistery Laboratory, Medicine Faculty, Auvergne University, 63000 Clermont-Ferrand, France
| |
Collapse
|
8
|
Bernard Y, Bonnin N, Farguette F, Chiambaretta F. [Tolerability and short-term efficacy of the Ozurdex® dexamethasone intravitreal implant for treatment of uveitic cystoid macular edema: A retrospective study of 52 injections performed at the Clermont-Ferrand teaching hospital]. J Fr Ophtalmol 2015; 39:1-4. [PMID: 26616298 DOI: 10.1016/j.jfo.2015.07.009] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2015] [Revised: 06/28/2015] [Accepted: 07/02/2015] [Indexed: 11/26/2022]
Abstract
Macular edema is the main cause of decreased visual acuity in uveitis and determines the visual prognosis. We retrospectively analyzed the tolerability and efficacy of the dexamethasone intravitreal implant in the management of uveitis. Twenty-five patients with uveitic cystoid macular edema were all treated with the Ozurdex(®) dexamethasone intravitreal implant from January 2012 to August 2014. The main outcome measures were visual acuity recovery, changes in macular thickness and resolution of the vitritis. Thirty-two eyes of 25 patients received 52 injections of Ozurdex(®). Both complete regression of the macular edema and resolution of the vitritis occurred in 100 % patients. Visual acuity improved in 62 % of patients: the mean reduction in macular thickness was 252 (±171μm); the mean time between injections was 6.7 (±3.8) months. Secondary ocular hypertension was seen in 33 % of patients. No patient required secondary surgery although a selective laser trabeculoplasty was required for one patient. The dexamethasone intravitreal implant Ozurdex(®) resulted in continuous and complete regression of uveitic cystoid macular edema. It allows evaluation of the potential visual recovery of treated eyes. The tolerability and duration of action provide a rationale for considering Ozurdex(®) as a first-line therapy for uveitis which remains uncontrolled despite optimal systemic treatment.
Collapse
Affiliation(s)
- Y Bernard
- Service de neuroradiologie, pôle radiologie, CHU de Clermont-Ferrand, EA 7281 R2D2, biochemistry laboratory, medicine faculty, Auvergne university, 63000 Clermont-Ferrand, France
| | - N Bonnin
- RMND-M2O pole, ophthalmology department, Clermont-Ferrand university hospital, 63000 Clermont-Ferrand, France; Service de neuroradiologie, pôle radiologie, CHU de Clermont-Ferrand, EA 7281 R2D2, biochemistry laboratory, medicine faculty, Auvergne university, 63000 Clermont-Ferrand, France.
| | - F Farguette
- Service de neuroradiologie, pôle radiologie, CHU de Clermont-Ferrand, EA 7281 R2D2, biochemistry laboratory, medicine faculty, Auvergne university, 63000 Clermont-Ferrand, France
| | - F Chiambaretta
- RMND-M2O pole, ophthalmology department, Clermont-Ferrand university hospital, 63000 Clermont-Ferrand, France; Service de neuroradiologie, pôle radiologie, CHU de Clermont-Ferrand, EA 7281 R2D2, biochemistry laboratory, medicine faculty, Auvergne university, 63000 Clermont-Ferrand, France
| |
Collapse
|
9
|
Pham Dang N, Zitte K, Bonnin N, Delbet-Dupas C, Barthélémy I. [Aseptic serous cellulitis of the right hemiface following a retrobulbar alcohol injection]. J Fr Ophtalmol 2015; 39:e33-5. [PMID: 26549140 DOI: 10.1016/j.jfo.2015.04.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2015] [Revised: 04/02/2015] [Accepted: 04/10/2015] [Indexed: 10/22/2022]
Affiliation(s)
- N Pham Dang
- Service de chirurgie maxillo-faciale et stomatologie, NHE, CHU de Clermont-Ferrand, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand, France; UMR Inserm/UdA, U1107, Neuro-Dol, Trigeminal Pain and Migraine, université d'Auvergne, BP 10448, 63000 Clermont-Ferrand, France.
| | - K Zitte
- Service d'ophtalmologie, CHU de Clermont-Ferrand, Gabriel-Montpied, 58, rue Montalembert, 63000 Clermont-Ferrand, France
| | - N Bonnin
- Service d'ophtalmologie, CHU de Clermont-Ferrand, Gabriel-Montpied, 58, rue Montalembert, 63000 Clermont-Ferrand, France
| | - C Delbet-Dupas
- Service de chirurgie maxillo-faciale et stomatologie, NHE, CHU de Clermont-Ferrand, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand, France
| | - I Barthélémy
- Service de chirurgie maxillo-faciale et stomatologie, NHE, CHU de Clermont-Ferrand, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand, France; UMR Inserm/UdA, U1107, Neuro-Dol, Trigeminal Pain and Migraine, université d'Auvergne, BP 10448, 63000 Clermont-Ferrand, France; Faculté de médecine, Clermont université, université d'Auvergne, BP 10448, 63000 Clermont-Ferrand, France
| |
Collapse
|
10
|
Maurin C, Daniel E, Bonnin N, Pereira B, Monneyron N, Peltier C, Monier F, Chiambaretta F. [Assessment of postoperative pain after corneal collagen cross-linking by iontophoresis vs the rapid epithelium-off technique in progressive keratoconus patients]. J Fr Ophtalmol 2015; 38:904-11. [PMID: 26542679 DOI: 10.1016/j.jfo.2015.05.006] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2015] [Revised: 05/02/2015] [Accepted: 05/13/2015] [Indexed: 10/22/2022]
Abstract
INTRODUCTION Cross-linking (CXL) increases corneal biomechanical strength in progressive keratoconus. Since riboflavin cannot penetrate intact corneal epithelium, removal of epithelium is necessary for the classic CXL procedure (epi-off), but can cause severe postoperative pain. To avoid this problem, a method preserving the epithelium (epi-on) is used. In this study, we aimed to evaluate and compare postoperative pain after epi-off CXL and epi-on CXL. MATERIALS AND METHODS We present a retrospective study assessing the level of pain postoperatively in 38 patients between the age of 12 and 53 years who underwent CXL procedures at the University Hospital of Clermont-Ferrand from July 2013 to May 2014. Epi-off consisted of manual corneal de-epithelialization and riboflavin instillation for 20minutes, followed by UVA exposure for 9minutes. The epi-on technique used an applicator on the eye, filled with riboflavin, and a generator delivered a continuous low-level current for 5minutes. The duration of light exposure was similar in both groups. Postoperative medications were the same for both techniques. Assessment of pain and analgesic intake were reported by the patient on paper questionnaires. Pain was evaluated from preoperatively up until the end of the month. Statistical analyses were performed in bilateral formulation to an alpha type I and error risk of 5%. RESULTS Twenty-three epi-off patients and 15 epi-on patients. Twenty-nine men and 9 women (76.3%/23.7%). Mean age: 28 years. Reference base time was the return from the operating room. In the epi-off group, pain increased significantly until the morning of D2 and did not return to its intraoperative level until noon D2, 1.8±2.0 vs 2.5±2.5 (P=0.12). Pain remained stable until the morning of D4. From noon D4 until D30, it was significantly less than intraoperatively 1.8±2.0 vs 0.7±1.4 (P=0.01). In the epi-on group, pain was significantly higher than intraoperatively until noon of D1 2.5±2.2 vs 3.8±2.5 (P=0.01). From the evening of D1, it returned to its intraoperative level until the evening of D2 2.5±2.2 vs 2±1.7 (P=0.34). From the morning of D3 it was significantly less than intraoperatively 2.5±2.2 vs 0.8±0.9 (P=0.001). Considering all measurement times, there was no significant difference between the two groups (P=0.75), except from evening of D2 until evening of D3 in favor of iontophoresis: 1.9±2.3 vs 1.0±1.3 (P=0.038). DISCUSSION Epi-on seems less painful in the short term (up to noon of D1 for epi-on vs morning of D2 for epi-off) and with a shorter duration than epi-off. This can be explained by the absence of corneal de-epithelialization. However, the reduction in pain is not significant at all postoperative times, and a risk of epithelial abrasion during placement and removal of the corneal applicator may exist. CONCLUSION Iontophoresis maintains the corneal epithelium, decreases pain and improves patient comfort. A new study involving more patients and strict monitoring of medication intake would strengthen the validity of these results.
Collapse
Affiliation(s)
- C Maurin
- Service d'ophtalmologie, CHU de Clermont-Ferrand, 58, rue Montalembert, 63003 Clermont-Ferrand cedex, France.
| | - E Daniel
- Service d'ophtalmologie, CHU de Clermont-Ferrand, 58, rue Montalembert, 63003 Clermont-Ferrand cedex, France
| | - N Bonnin
- Service d'ophtalmologie, CHU de Clermont-Ferrand, 58, rue Montalembert, 63003 Clermont-Ferrand cedex, France
| | - B Pereira
- Délégation recherche clinique et innovation, CHU de Clermont-Ferrand, Villa annexe IFSI, 58, rue Montalembert, 63003 Clermont-Ferrand cedex, France
| | - N Monneyron
- Service d'ophtalmologie, CHU de Clermont-Ferrand, 58, rue Montalembert, 63003 Clermont-Ferrand cedex, France
| | - C Peltier
- Service d'ophtalmologie, CHU de Clermont-Ferrand, 58, rue Montalembert, 63003 Clermont-Ferrand cedex, France
| | - F Monier
- Service d'ophtalmologie, CHU de Clermont-Ferrand, 58, rue Montalembert, 63003 Clermont-Ferrand cedex, France
| | - F Chiambaretta
- Service d'ophtalmologie, CHU de Clermont-Ferrand, 58, rue Montalembert, 63003 Clermont-Ferrand cedex, France
| |
Collapse
|
11
|
Huard M, Bonnin N, Bacin F, Kemeny JL, Desjardins L, Chiambaretta F. [Case report of cholesterolosis bulbi in a Coats disease]. J Fr Ophtalmol 2015; 38:e139-41. [PMID: 26099426 DOI: 10.1016/j.jfo.2015.04.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2015] [Revised: 03/26/2015] [Accepted: 04/10/2015] [Indexed: 10/23/2022]
Affiliation(s)
- M Huard
- RMND-M2O Pole, Ophthalmology department, Clermont-Ferrand University Hospital, 58, rue Montalembert, 63000 Clermont-Ferrand, France
| | - N Bonnin
- RMND-M2O Pole, Ophthalmology department, Clermont-Ferrand University Hospital, 58, rue Montalembert, 63000 Clermont-Ferrand, France; EA 7281 R2D2, Biochemistry Laboratory, Medicine Faculty, Auvergne University, 28, place Henri-Dunant, 63001 Clermont-Ferrand, France.
| | - F Bacin
- RMND-M2O Pole, Ophthalmology department, Clermont-Ferrand University Hospital, 58, rue Montalembert, 63000 Clermont-Ferrand, France
| | - J-L Kemeny
- Biology Pole, Pathology department, Clermont-Ferrand University Hospital, 58, rue Montalembert, 63000 Clermont-Ferrand, France
| | - L Desjardins
- Onco-ophtalmology department, Curie Institute, 26, rue d'Ulm, 75005 Paris, France
| | - F Chiambaretta
- RMND-M2O Pole, Ophthalmology department, Clermont-Ferrand University Hospital, 58, rue Montalembert, 63000 Clermont-Ferrand, France; EA 7281 R2D2, Biochemistry Laboratory, Medicine Faculty, Auvergne University, 28, place Henri-Dunant, 63001 Clermont-Ferrand, France
| |
Collapse
|
12
|
Joubert R, Bonnin N, Kemeny JL, Moluçon-Chabrot C, Tournilhac O, Bacin F, Chiambaretta F. [Intraocular lymphoma associated with primary malignant lymphoma of the central nervous system: Seven-year experience of a tertiary center]. J Fr Ophtalmol 2015; 38:559-66. [PMID: 25976140 DOI: 10.1016/j.jfo.2015.03.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2015] [Revised: 03/17/2015] [Accepted: 03/20/2015] [Indexed: 10/23/2022]
Abstract
INTRODUCTION Primary intraocular lymphoma (PIOL), associated with primary central nervous system lymphoma (PCNSL), is a rare malignancy disease. By way of a seven-year experience of a tertiary center, we discuss the presentation and we review the diagnostic and therapeutic modalities. OBSERVATIONS We report six cases of PIOL associated with PCNSL. For all patients, the clinical presentation was a vitreoretinal syndrome. The diagnosis was histologically confirmed by vitreal sample or brain biopsy. Five patients developed a diffuse large B-cell lymphoma. Only one patient developed a T-cell lymphoma. The treatment consisted of conformational radiation therapy, systemic chemotherapy and intravitreal injections of methotrexate. The median survival after the diagnosis was 24 months. DISCUSSION PIOL, associated with PCNSL, is the most common type of ocular lymphoma. In most cases, ocular manifestations inaugurate the disease. PIOL is often fatal because of ultimate central nervous system presentation. The role of the ophthalmologist consists in early diagnosis. Typical clinical findings include vitroretinal tumor syndrome but can mascarade other eye pathologies. Diagnosis requires histology. The majority of PIOL is diffused large B-cell lymphoma. Decisions are made through multidisciplinary consultation. PIOL exhibits high responsiveness to methotrexate. CONCLUSION Through a literature review and many illustrations, we discuss epidemiological, clinical, histological, radiological and treatment characteristics of PIOL associated with PCNSL.
Collapse
Affiliation(s)
- R Joubert
- Service d'ophtalmologie, pôle médecine interne-ophtalmologie-ORL, CHU de Clermont-Ferrand, 58, rue Montalembert, 63000 Clermont-Ferrand, France
| | - N Bonnin
- Service d'ophtalmologie, pôle médecine interne-ophtalmologie-ORL, CHU de Clermont-Ferrand, 58, rue Montalembert, 63000 Clermont-Ferrand, France; EA 7281 R2D2, Biochemistry Laboratory, Medicine Faculty, Auvergne University, 28, place Henri-Dunant, 63001 Clermont-Ferrand, France.
| | - J-L Kemeny
- Service anatomopathologie, centre de biochimie, CHU de Clermont-Ferrand, 58, rue Montalembert, 63000 Clermont-Ferrand, France
| | - C Moluçon-Chabrot
- Hématologie clinique, CHU de Clermont-Ferrand, 58, rue Montalembert, 63000 Clermont-Ferrand, France
| | - O Tournilhac
- Hématologie clinique, CHU de Clermont-Ferrand, 58, rue Montalembert, 63000 Clermont-Ferrand, France
| | - F Bacin
- Service d'ophtalmologie, pôle médecine interne-ophtalmologie-ORL, CHU de Clermont-Ferrand, 58, rue Montalembert, 63000 Clermont-Ferrand, France
| | - F Chiambaretta
- Service d'ophtalmologie, pôle médecine interne-ophtalmologie-ORL, CHU de Clermont-Ferrand, 58, rue Montalembert, 63000 Clermont-Ferrand, France; EA 7281 R2D2, Biochemistry Laboratory, Medicine Faculty, Auvergne University, 28, place Henri-Dunant, 63001 Clermont-Ferrand, France
| |
Collapse
|
13
|
Bonnin N, Borel A, Daniel E, Tiple A, Joubert R, Heng AE, Chiambaretta F. [Meretoja syndrome: Identification of a family and description of the corneal involvement by confocal microscopy]. J Fr Ophtalmol 2015; 38:e111-5. [PMID: 25913657 DOI: 10.1016/j.jfo.2014.10.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2014] [Revised: 10/13/2014] [Accepted: 10/27/2014] [Indexed: 10/23/2022]
Affiliation(s)
- N Bonnin
- RMND-M2O Pole, Ophthalmology department, Clermont-Ferrand University Hospital, 58, rue Montalembert, 63000 Clermont-Ferrand, France; EA 7281 R2D2, Biochemistry Laboratory, Medicine Faculty, Auvergne University, 28, place Henri-Dunant, 63001 Clermont-Ferrand, France.
| | - A Borel
- Service d'ophtalmologie, centre hospitalier Vichy, boulevard Denière, 03200 Vichy, France
| | - E Daniel
- RMND-M2O Pole, Ophthalmology department, Clermont-Ferrand University Hospital, 58, rue Montalembert, 63000 Clermont-Ferrand, France
| | - A Tiple
- Nephrology Department, Clermont-Ferrand University Hospital, 58, rue Montalembert, 63000 Clermont-Ferrand, France
| | - R Joubert
- RMND-M2O Pole, Ophthalmology department, Clermont-Ferrand University Hospital, 58, rue Montalembert, 63000 Clermont-Ferrand, France
| | - A-E Heng
- Nephrology Department, Clermont-Ferrand University Hospital, 58, rue Montalembert, 63000 Clermont-Ferrand, France
| | - F Chiambaretta
- RMND-M2O Pole, Ophthalmology department, Clermont-Ferrand University Hospital, 58, rue Montalembert, 63000 Clermont-Ferrand, France; EA 7281 R2D2, Biochemistry Laboratory, Medicine Faculty, Auvergne University, 28, place Henri-Dunant, 63001 Clermont-Ferrand, France
| |
Collapse
|
14
|
Zitte K, Farguette F, Bonnin N, Bacin F, Chiambaretta F. Syndrome des taches blanches évanescentes associé à une sclérose tubéreuse de Bourneville : à propos d’un cas. J Fr Ophtalmol 2015; 38:e77-85. [DOI: 10.1016/j.jfo.2014.04.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2014] [Accepted: 04/28/2014] [Indexed: 10/23/2022]
|
15
|
Rebika S, Bonnin N, Borel A, Mrozek N, Vidal M, Rousseau E, Bacin F, Chiambaretta F. [Ocular involvement with Candida albicans: report of 2 cases]. J Fr Ophtalmol 2015; 38:301-5. [PMID: 25842148 DOI: 10.1016/j.jfo.2014.10.011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2014] [Revised: 10/12/2014] [Accepted: 10/27/2014] [Indexed: 11/30/2022]
Abstract
INTRODUCTION Ocular involvement by Candida albicans is rare and may present as endogenous endophthalmitis or choroiditis. It occurs in the context of C. albicans septicemia, in the context of intensive care unit hospitalization or intravenous drug use. We report two cases referred to our department with different characteristics, background, diagnostic modalities and different courses. OBSERVATIONS A 37-year-old woman, with a history of intravenous drug use, presented with C. albicans endophthalmitis. Intravenous combination antifungal therapy was begun, but vitrectomy and intravitreal amphotericin B were performed due to worsening of the endophthalmitis. The second case was a 53-year-old man who was hospitalized in the intensive care unit for C. albicans septicemia with a left macular chorioretinitis. Intravenous antifungal therapy was initiated and allowed regression of the ocular lesion. DISCUSSION Our cases illustrate both types of ophthalmic involvement by candidiasis requiring different treatments with well-described recommendations: in the case of endophthalmitis, the use of vitrectomy and intravitreal amphotericin B injection in association with intravenous antifungal treatment, whereas parenteral antifungal treatment is often sufficient in the case of chorioretinitis. CONCLUSION Early detection, initiation of treatment and ophthalmologic monitoring are difficult but necessary in these populations non-compliant with follow-up or in intensive care units. The management of ocular candidiasis requires good collaboration between the ophthalmology, infectious diseases and intensive care unit departments.
Collapse
Affiliation(s)
- S Rebika
- RMND-M2O pole, ophthalmology department, Clermont-Ferrand university hospital, 63000 Clermont-Ferrand, France.
| | - N Bonnin
- RMND-M2O pole, ophthalmology department, Clermont-Ferrand university hospital, 63000 Clermont-Ferrand, France; EA 7281 R2D2, biochemistry laboratory, medicine faculty, Auvergne university, 63000 Clermont-Ferrand, France
| | - A Borel
- RMND-M2O pole, ophthalmology department, Clermont-Ferrand university hospital, 63000 Clermont-Ferrand, France
| | - N Mrozek
- RHEUNNIRS pole, infectious diseases department, Clermont-Ferrand university hospital, 63003 Clermont-Ferrand, France
| | - M Vidal
- RHEUNNIRS pole, infectious diseases department, Clermont-Ferrand university hospital, 63003 Clermont-Ferrand, France
| | - E Rousseau
- RMND-M2O pole, ophthalmology department, Clermont-Ferrand university hospital, 63000 Clermont-Ferrand, France
| | - F Bacin
- RMND-M2O pole, ophthalmology department, Clermont-Ferrand university hospital, 63000 Clermont-Ferrand, France
| | - F Chiambaretta
- RMND-M2O pole, ophthalmology department, Clermont-Ferrand university hospital, 63000 Clermont-Ferrand, France; EA 7281 R2D2, biochemistry laboratory, medicine faculty, Auvergne university, 63000 Clermont-Ferrand, France
| |
Collapse
|
16
|
Zitte K, Bonnin N, Kémény JL, Bacin F, Mulliez A, Chiambaretta F. [DSAEK after failed penetrating keratoplasty]. J Fr Ophtalmol 2015; 38:22-33. [PMID: 25575419 DOI: 10.1016/j.jfo.2014.06.009] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2014] [Revised: 06/29/2014] [Accepted: 06/30/2014] [Indexed: 10/24/2022]
Abstract
PURPOSE To report the anatomic and functional outcomes of Descemet's stripping automated endothelial keratoplasty (DSAEK) in 32 eyes after failed penetrating keratoplasty (PK). SUBJECTS AND METHODS This retrospective, single-center observational study was performed on 32 eyes of 26 patients with failed PK grafts who underwent DSAEK between June 2009 and June 2013 at Clermont-Ferrand University Medical Center. Primary outcomes measured were: graft survival rates, functional improvement (visual acuity), and complications. RESULTS Mean follow-up was 16.45 months [6-36]. Graft survival at 12 months was 76.1 % [68.1-82.3]. PK grafts cleared in 75 % of cases. Eight primary DSAEKs detached and/or decentered early (prior to day 8, average 6.22 days): 3 underwent repeat DSAEK with a new graft, and 3 underwent conversion to PK. Results were available for 26 patients at 6 months. Mean preoperative best-corrected visual acuity (BCVA) in logMAR increased from 1.48 (counting fingers at 2 meters) to 0.996 logMAR (1/10) at 6 months. BCVA improved in 17 patients (68 %). BCVA improved an average of 5.2 lines (P=0.0006). Eight patients had a large number of comorbid conditions that limited final visual acuity. DISCUSSION Anatomic outcomes are similar to other studies. Final average BCVA was limited by severe comorbid conditions and performance of DSAEK solely for comfort. Many surgical strategies have been described to decrease graft dislocation and primary graft failure. Adapting graft trephine diameter to the host cornea as measured by AS-OCT, using a nomogram based on posterior corneal curvature obtained on AS-OCT, may be an interesting approach. CONCLUSION DSAEK allows for quick visual recovery by preserving the anterior corneal curvature. It is an essential option for restoring corneal clarity in PK failure due to endothelial decompensation. A longer follow-up would allow a comparison of graft survival for the two techniques in this context.
Collapse
Affiliation(s)
- K Zitte
- RMND-M2O Pole, Ophthalmology department, Clermont-Ferrand University Hospital, 58, rue Montalembert, 63000 Clermont-Ferrand, France.
| | - N Bonnin
- RMND-M2O Pole, Ophthalmology department, Clermont-Ferrand University Hospital, 58, rue Montalembert, 63000 Clermont-Ferrand, France; EA 7281 R2D2, Biochemistry Laboratory, Medicine Faculty, Auvergne University, 63000 Clermont-Ferrand, France
| | - J-L Kémény
- Biology Pole, Pathology department, Clermont-Ferrand University Hospital, 63000 Clermont-Ferrand, France
| | - F Bacin
- RMND-M2O Pole, Ophthalmology department, Clermont-Ferrand University Hospital, 58, rue Montalembert, 63000 Clermont-Ferrand, France
| | - A Mulliez
- Délégation à la recherche clinique et à l'innovation, Clermont-Ferrand University Hospital, 63000 Clermont-Ferrand, France
| | - F Chiambaretta
- RMND-M2O Pole, Ophthalmology department, Clermont-Ferrand University Hospital, 58, rue Montalembert, 63000 Clermont-Ferrand, France; EA 7281 R2D2, Biochemistry Laboratory, Medicine Faculty, Auvergne University, 63000 Clermont-Ferrand, France
| |
Collapse
|
17
|
Rebika S, Bonnin N, Kémény JL, Chiambaretta F, Bacin F. [Apropos of 5 cases of optic nerve tumors diagnosed during a 6-year-period]. J Fr Ophtalmol 2014; 38:13-21. [PMID: 25542442 DOI: 10.1016/j.jfo.2014.06.011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2014] [Revised: 06/25/2014] [Accepted: 06/30/2014] [Indexed: 02/08/2023]
Abstract
INTRODUCTION Optic nerve tumors are uncommon and rarely described. By way of five patients treated at the University Hospital of Clermont-Ferrand, France, over a six-year-period, we discuss their clinical and radiological characteristics, their treatment and their course. OBSERVATIONS We report two cases of optic nerve glioma in small children, two cases of optic nerve sheath meningioma and a 57-year-old patient treated for lung cancer with an optic nerve metastasis and choroidal and brain metastases. The diagnosis was confirmed by imaging in all patients and histologically for the cases of optic nerve glioma. RESULTS The children with glioma were exclusively treated with chemotherapy, the two women with meningioma exclusively with radiation therapy, and the man with the optic nerve metastasis by chemotherapy and radiotherapy. The tumors were stabilized in all cases except for a progression in one case of glioma, one year after treatment. DISCUSSION Gliomas and meningiomas are the most frequent tumors; other tumors are rare. Through a literature review and many illustrations, we discuss epidemiologic, clinical and radiologic characteristics, treatment and course of these uncommon tumors. CONCLUSION The diagnosis of optic nerve tumors must be considered in cases of anterior or posterior progressive optic neuropathy. Treatment must be a compromise between effective treatment of the tumor and preservation of visual function. Decisions are made through multidisciplinary consultations, in which the role of the ophthalmologist is crucial for the diagnosis and success of the treatment.
Collapse
Affiliation(s)
- S Rebika
- Pôle médecine interne-ophtalmologie-ORL, service d'ophtalmologie, CHU de Clermont-Ferrand, 63003 Clermont-Ferrand, France.
| | - N Bonnin
- Pôle médecine interne-ophtalmologie-ORL, service d'ophtalmologie, CHU de Clermont-Ferrand, 63003 Clermont-Ferrand, France
| | - J-L Kémény
- Centre de biochimie, service anatomopathologie, de CHU Clermont-Ferrand, 63003 Clermont-Ferrand, France
| | - F Chiambaretta
- Pôle médecine interne-ophtalmologie-ORL, service d'ophtalmologie, CHU de Clermont-Ferrand, 63003 Clermont-Ferrand, France
| | - F Bacin
- Pôle médecine interne-ophtalmologie-ORL, service d'ophtalmologie, CHU de Clermont-Ferrand, 63003 Clermont-Ferrand, France
| |
Collapse
|
18
|
Biau J, Miroir J, Loos G, Saroul N, Bonnin N, Berger L, Millardet C, Moreira J, Lapeyre M. Étude prospective de la radiothérapie conformationnelle avec modulation d’intensité par RapidArc® des cancers des fosses nasales et paranasales. Cancer Radiother 2014. [DOI: 10.1016/j.canrad.2014.07.119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
19
|
Tardif A, Bonnin N, Borel A, Viennet A, Pereira B, Chiambaretta F. [Selective laser trabeculoplasty: results after a first and a second session, overall comparison and results for three indications]. J Fr Ophtalmol 2014; 37:353-7. [PMID: 24679450 DOI: 10.1016/j.jfo.2013.08.008] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2013] [Revised: 07/22/2013] [Accepted: 08/26/2013] [Indexed: 11/18/2022]
Abstract
PURPOSE To compare the results obtained with SLT trabeculoplasty after an initial treatment (SLT-1) and after a second treatment (SLT-2). Subgroup analysis according to trabecular pigmentation and the existence of a high myopia. MATERIALS AND METHODS Retrospective study of 77 patients, 152 SLT sessions performed in the Ophthalmology Department of Clermont-Ferrand University Medical Center, 118 SLT-1, 34 SLT-2. Three comparable groups of patients were assembled: group 1 (glaucoma patients with normal or subnormal trabecular pigmentation), group 2 (glaucoma patients with high myopia), and group 3 (glaucoma patients with significant trabecular pigmentation). The results were compared between groups, for SLT-1 and SLT-2. RESULTS Intraocular pressure lowering was consistent with data reported in the literature. Comparison of the results of SLT-1 versus SLT-2 did not find any significant difference in terms of IOP change. However, after SLT-2, the IOP response appears significantly greater (P=0.03) in the group with significant trabecular pigmentation compared to the non-myopic group with normal trabecular pigmentation. DISCUSSION Our results are consistent with the literature for efficacy, tolerance and reproducibility of SLT. No reduction in SLT efficacy was observed after a second session. Trabecular pigmentation is not a predictor of the response after the first session. In the case of retreatment (SLT-2), the differences observed lead to the hypothesis that it may be appropriate to perform at least two SLT treatments in patients with significant trabecular pigmentation in order to obtain maximal effect. Myopia, a variable not previously studied, does not seem to influence SLT outcomes. CONCLUSION Trabecular pigmentation and the presence of myopia do not appear to be predictive of a successful first treatment. However, our study leads us to suggest the hypothesis that the maximal response of SLT in patients with significant trabecular pigmentation is not obtained until after at least two sessions. This observation opens an interesting perspective on the therapeutic strategy to adopt in the case of pigmentary glaucoma.
Collapse
Affiliation(s)
- A Tardif
- Service d'ophtalmologie, pôle RMND-M2O, CHU de Clermont-Ferrand, 58, rue Montalembert, 63003 Clermont-Ferrand, France
| | - N Bonnin
- Service d'ophtalmologie, pôle RMND-M2O, CHU de Clermont-Ferrand, 58, rue Montalembert, 63003 Clermont-Ferrand, France.
| | - A Borel
- Service d'ophtalmologie, pôle RMND-M2O, CHU de Clermont-Ferrand, 58, rue Montalembert, 63003 Clermont-Ferrand, France
| | - A Viennet
- Service d'ophtalmologie, pôle RMND-M2O, CHU de Clermont-Ferrand, 58, rue Montalembert, 63003 Clermont-Ferrand, France
| | - B Pereira
- Department of Clinical Research and Innovation (DRCI), CHU de Clermont-Ferrand, Villa Annexe IFSI, rue Montalembert, 63000 Clermont-Ferrand, France
| | - F Chiambaretta
- Service d'ophtalmologie, pôle RMND-M2O, CHU de Clermont-Ferrand, 58, rue Montalembert, 63003 Clermont-Ferrand, France
| |
Collapse
|
20
|
Chassang B, Bonnin N, Moisset X, Citron B, Clavelou P, Chiambaretta F. Two cases of bilateral amiodarone-associated optic neuropathy. J Fr Ophtalmol 2014; 37:231-6. [PMID: 24576569 DOI: 10.1016/j.jfo.2013.12.004] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2013] [Accepted: 12/09/2013] [Indexed: 11/28/2022]
Abstract
INTRODUCTION The widespread use of amiodarone is limited by its toxicity, notably to the optic nerve. We report two cases of bilateral optic nerve neuropathy due to amiodarone, and provide a detailed description of the disease. OBSERVATIONS The first case was a 59-year-old man complaining from insidious monocular loss of vision within ten months of initiating amiodarone. Funduscopy and optical coherence tomography showed bilateral optic disc edema. The second case was a 72-year-old man presenting with a decrease in visual acuity in his left eye for a month. Funduscopy showed a left optic nerve edema, and fluorescein angiography showed bilateral papillitis. In both cases, the clinical presentation was not suggestive of ischemic neuropathy, because of the preservation of visual acuity and the insidious onset. In addition, both cardiovascular and inflammatory work-up were normal. An amiodarone-associated neuropathy was suspected, and amiodarone was discontinued with the approval of the cardiologist, with complete regression of the papilledema and a stabilization of visual symptoms. DISCUSSION Differentiating between amiodarone-associated optic neuropathy and anterior ischemic optic neuropathy may be complicated by the cardiovascular background of such patients. The major criterion is the absence of a severe decrease in visual acuity; other criteria are the normality of cardiovascular and inflammatory work-up, and the improvement or the absence of worsening of symptoms after discontinuation of amiodarone. CONCLUSION Amiodarone-associated neuropathy remains a diagnosis of exclusion, and requires amiodarone discontinuation, which can only be done with the approval of a cardiologist, and sometimes requires replacement therapy.
Collapse
Affiliation(s)
- B Chassang
- RMND-M2O Pole, Ophthalmology department, Clermont-Ferrand University Hospital, 63000 Clermont-Ferrand, France
| | - N Bonnin
- RMND-M2O Pole, Ophthalmology department, Clermont-Ferrand University Hospital, 63000 Clermont-Ferrand, France; EA 7281 R2D2, Biochemistery Laboratory, Medicine Faculty, Auvergne University, 63000 Clermont-Ferrand, France.
| | - X Moisset
- RMND-M2O Pole, Neurology department, Clermont-Ferrand University Hospital, 63000 Clermont-Ferrand, France
| | - B Citron
- Medical and Surgical Cardiology Pole, Cardiology department, Clermont-Ferrand University Hospital, 63000 Clermont-Ferrand, France
| | - P Clavelou
- RMND-M2O Pole, Neurology department, Clermont-Ferrand University Hospital, 63000 Clermont-Ferrand, France
| | - F Chiambaretta
- RMND-M2O Pole, Ophthalmology department, Clermont-Ferrand University Hospital, 63000 Clermont-Ferrand, France; EA 7281 R2D2, Biochemistery Laboratory, Medicine Faculty, Auvergne University, 63000 Clermont-Ferrand, France
| |
Collapse
|
21
|
Bonnin N, Rousseau E, André M, Aumaître O, Bacin F, Chiambaretta F. Uvéite syphilitique et surdité : à propos d’un cas. J Fr Ophtalmol 2013; 36:589-93. [DOI: 10.1016/j.jfo.2012.11.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2012] [Revised: 11/09/2012] [Accepted: 11/12/2012] [Indexed: 10/27/2022]
|
22
|
Resseguier AS, Guettrot-Imbert G, Bonnin N, Hermet M, Bardy A, Delèvaux I, Aumaitre O, Andre M, Chiambaretta F. Épithéliopathie en plaques révélant une artérite à cellules géantes. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.03.111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
23
|
Joubert R, Bonnin N, Chiambaretta F, Bacin F. [Combined hamartoma of the retinal pigment epithelium and retina: case report]. J Fr Ophtalmol 2013; 36:533-6. [PMID: 23618734 DOI: 10.1016/j.jfo.2013.03.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2012] [Revised: 02/22/2013] [Accepted: 03/05/2013] [Indexed: 11/15/2022]
Abstract
We report the case of a 19-year-old woman with a combined hamartoma of the retinal pigment epithelium and retina incidentally discovered during her first eye exam. By way of this case, we describe and illustrate the epidemiological and clinical characteristics of the condition and its potential complications.
Collapse
Affiliation(s)
- R Joubert
- Service d'ophtalmologie, pôle médecine interne-ophtalmologie-ORL, CHU de Clermont-Ferrand, 58, rue Montalembert, 63003 Clermont-Ferrand, France
| | | | | | | |
Collapse
|
24
|
Borel A, Bonnin N, Porte C, Chiambaretta F, Bacin F. Papillopathie traumatique : à propos d’un cas d’arrachement partiel du nerf optique. J Fr Ophtalmol 2013; 36:372-7. [DOI: 10.1016/j.jfo.2012.08.003] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2011] [Revised: 08/09/2012] [Accepted: 08/27/2012] [Indexed: 10/27/2022]
|
25
|
Bonnin N, Boyle H, Rivoire M, Bailly C, Droz J, Flechon A. Teratoma with Malignant Transformation (TMT) in Men with Germ Cell Tumors (GCTS): Retrospective Study of 26 Cases from a Single Institution. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)33438-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
26
|
Bonnin N, Nezzar H, Dubray C, Renault D, Olmiere C, Chiambaretta F. Plasma levels and systemic safety of 0.1% unpreserved Timolol maleate gel, 0.5% Timolol aqueous solution and 0.5% Timolol maleate gel. J Fr Ophtalmol 2012; 35:9-16. [DOI: 10.1016/j.jfo.2011.03.012] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2011] [Revised: 02/22/2011] [Accepted: 03/09/2011] [Indexed: 10/16/2022]
|
27
|
Duclos C, Bonnin N, Merlin E, Viorel A, Lacombe P, Dalens H, Chiambaretta F, Deméocq F, Chazal J, Kanold J. Hypertension intracrânienne bénigne, mais pas anodine. À propos d’un cas. Arch Pediatr 2010; 17:1677-81. [DOI: 10.1016/j.arcped.2010.09.012] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2009] [Revised: 01/21/2010] [Accepted: 09/16/2010] [Indexed: 10/18/2022]
|
28
|
Bonnin N, Thomas V, Gabrillargues J, Bacin F. Fibrinolyse intra-artérielle in situ chez une patiente monophtalme atteinte d’occlusion d’artère centrale de rétine. J Fr Ophtalmol 2009; 32:415-9. [DOI: 10.1016/j.jfo.2009.04.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2008] [Accepted: 04/23/2009] [Indexed: 11/16/2022]
|
29
|
Abstract
The optic nerve glioma is a relatively rare pathology in children and only a few cases have been described in infants. This paper reports the symptoms of this exceptional case in a 4-month-old child and reviews the differential diagnoses at this age. Finally, we discuss the diagnosis and therapeutic possibilities.
Collapse
Affiliation(s)
- A Viennet
- Service d'Ophtalmologie, CHU, Clermont-Ferrand, France.
| | | | | | | | | | | | | | | |
Collapse
|
30
|
Borel A, Albertini E, Bonnin N, Bontemps C, Boyer A, Chopineau J, Chiambaretta F. 581 Une nouvelle ciclosporine A 1 % et 2 % : toxicité, tolérance et observance. J Fr Ophtalmol 2009. [DOI: 10.1016/s0181-5512(09)73705-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
31
|
Bonnin N, Ceruse P, Bachelot T, Zrounba P, Ramade A, Pommier P, Favrel V, Tartas S, Ferlay C, Fayette J. Efficacy of neoadjuvant TPF (nTPF; docetaxel, T; cisplatin, P; 5FU) in nonselected patients (pts) with head and neck cancer and subsequent radiotherapy (RT) combined with chemotherapy (CT) or cetuximab (Cx). J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.6074] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
32
|
Bonnin N, Thomas V, Gabrillargues J, Bacin F. 300 Cas de fibrinolyse intra-artérielle in situ chez une patiente monophtalme atteinte d’occlusion de l’artère centrale de rétine. J Fr Ophtalmol 2008. [DOI: 10.1016/s0181-5512(08)70897-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
33
|
Viennet A, Bonnin N, Chiamberetta F. 118 Destruction endothéliale cornéenne après injection intra-camérulaire d’antibiotique (gentamicine) lors d’une chirurgie de la cataracte : à propos d’une série de 8 cas. J Fr Ophtalmol 2008. [DOI: 10.1016/s0181-5512(08)70714-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
34
|
Bonnin N, Viennet A, Nezzar H, Dechelotte P, Barthelemy I, Demeocq F, Gabrillargues J, Campagne D, Rigal D, Bacin F. 448 Rhabdomyosarcome palpébral chez un enfant de deux ans. J Fr Ophtalmol 2007. [DOI: 10.1016/s0181-5512(07)80261-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
35
|
Viennet A, Bonnin N, Nezzar H, Sinardet D, Campagne D, Demeocq F, Kemeny J, Bacin F. 451 Gliome du nerf optique chez un enfant de 4 mois. J Fr Ophtalmol 2007. [DOI: 10.1016/s0181-5512(07)80264-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
36
|
Bonnin N. Problems facing the doctor in a changing world. Med J Aust 1965; 2:37-41. [PMID: 5846220 DOI: 10.5694/j.1326-5377.1966.tb19720.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|